- Home
- JNJ vs CHSCP Comparison
JNJ vs CHSCP Comparison
Compare JNJ & CHSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNJ
- CHSCP
- Stock Information
- Founded
- JNJ 1886
- CHSCP N/A
- Country
- JNJ United States
- CHSCP United States
- Employees
- JNJ N/A
- CHSCP N/A
- Industry
- JNJ Biotechnology: Pharmaceutical Preparations
- CHSCP Farming/Seeds/Milling
- Sector
- JNJ Health Care
- CHSCP Industrials
- Exchange
- JNJ Nasdaq
- CHSCP Nasdaq
- Market Cap
- JNJ N/A
- CHSCP N/A
- IPO Year
- JNJ 1944
- CHSCP N/A
- Fundamental
- Price
- JNJ $153.64
- CHSCP $28.23
- Analyst Decision
- JNJ Buy
- CHSCP
- Analyst Count
- JNJ 17
- CHSCP 0
- Target Price
- JNJ $169.76
- CHSCP N/A
- AVG Volume (30 Days)
- JNJ 9.5M
- CHSCP N/A
- Earning Date
- JNJ 01-22-2025
- CHSCP N/A
- Dividend Yield
- JNJ 3.22%
- CHSCP N/A
- EPS Growth
- JNJ N/A
- CHSCP N/A
- EPS
- JNJ 5.79
- CHSCP N/A
- Revenue
- JNJ $88,821,000,000.00
- CHSCP N/A
- Revenue This Year
- JNJ $3.46
- CHSCP N/A
- Revenue Next Year
- JNJ $3.93
- CHSCP N/A
- P/E Ratio
- JNJ $26.51
- CHSCP N/A
- Revenue Growth
- JNJ 4.30
- CHSCP N/A
- 52 Week Low
- JNJ $140.68
- CHSCP N/A
- 52 Week High
- JNJ $168.85
- CHSCP N/A
- Technical
- Relative Strength Index (RSI)
- JNJ 62.29
- CHSCP 46.25
- Support Level
- JNJ $150.78
- CHSCP $27.54
- Resistance Level
- JNJ $154.14
- CHSCP $28.73
- Average True Range (ATR)
- JNJ 2.57
- CHSCP 0.39
- MACD
- JNJ 0.87
- CHSCP -0.07
- Stochastic Oscillator
- JNJ 94.12
- CHSCP 47.76
About CHSCP CHS Inc. 8% Cumulative Redeemable Preferred Stock
CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).